The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
Open accessAbstract
Background: The proinflammatory cytokines interleukin 1β (IL-1β) and IL-18 are central players in the pathogenesis of inflammatory bowel disease (IBD). In response to a variety of microbial components and crystalline substances, both cytokines are processed via the caspase-1-activating multiprotein complex, the NLRP3 inflammasome. Here, the role of the NLRP3 inflammasome in experimental colitis induced by dextran sodium sulfate (DSS) was examined. Methods: IL-1β production in response to DSS was studied in macrophages of wild-type, caspase-1 −/− , NLRP3 −/− , ASC −/− , cathepsin B −/− or cathepsin L −/− mice. Colitis was induced in C57BL/6 and NLRP3 −/− mice by oral DSS administration. A clinical disease activity score was evaluated daily. Histological colitis severity and expression of cytokines were determined in colonic tissue. Results: Macrophages incubated with DSS in vitro secreted high levels of IL-1β in a caspase-1-dependent manner. IL-1β secretion was abrogated in macrophages lacking NLRP3, ASC or caspase-1, indicating that DSS activates caspase-1 via the NLRP3 inflammasome. Moreover, IL-1β secretion was dependent on phagocytosis, lysosomal maturation, cathepsin B and L, and reactive oxygen species (ROS). After oral administration of DSS, NLRP3 −/− mice developed a less severe colitis than wild-type mice and produced lower levels of proinflammatory cytokines in colonic tissue. Pharmacological inhibition of caspase-1 with pralnacasan achieved a level of mucosal protection comparable with NLRP3 deficiency. Conclusions: The NLRP3 inflammasome was identified as a critical mechanism of intestinal inflammation in the DSS colitis model. The NLRP3 inflammasome may serve as a potential target for the development of novel therapeutics for patients with IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Self-citationA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080 · cited 1×
“We could rule out that DSS, either directly or indirectly, induces NLRP3 inflammasome activation via the P2X7 receptor”
BackgroundHornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Self-citationInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Self-citationThe Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Self-citationOkayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., & Nakaya, R. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90290-h · Cited by 2,401
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production
Saitoh, T., Fujita, N., Jang, M. H., Uematsu, S., Yang, B.-G., Satoh, T., Omori, H., Noda, T., Yamamoto, N., Komatsu, M., et al. (2008) · Nature · doi:10.1038/nature07383 · Cited by 2,014
Rioux, J. D., Xavier, R. J., Taylor, K. D., Silverberg, M. S., Goyette, P., Huett, A., Green, T., Kuballa, P., Barmada, M. M., Datta, L. W., et al. (2007) · Nature Genetics · doi:10.1038/ng2032 · Cited by 1,769
Cited by
Pyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
“Using a common acute and chronic epithelial injury colitis model based on the administration of dextran sulphate to mice, several groups reported decreased disease severity in mice deficient in caspase-1 or NLRP3, which correlated with lower IL-1β production during diseas”
BackgroundNLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.97 · Cited by 1,885
Self-citationImmunopathogenesis of IBD: current state of the art
de Souza, H. S. P., & Fiocchi, C. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.186 · Cited by 1,551
Interleukin-18 and IL-18 Binding Protein
Dinarello, C. A., Novick, D., Kim, S., & Kaplanski, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00289 · Cited by 938
NLRP3 and pyroptosis blockers for treating inflammatory diseases
Coll, R. C., Schroder, K., & Pelegrín, P. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.04.003 · Cited by 755
Targeting immune cell circuits and trafficking in inflammatory bowel disease
Neurath, M. F. (2019) · Nature Immunology · doi:10.1038/s41590-019-0415-0 · Cited by 701
NLRP3 Inflammasome and Inflammatory Bowel Disease
Zhen, Y., & Zhang, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00276 · Cited by 649
Diverging inflammasome signals in tumorigenesis and potential targeting
Karki, R., & Kanneganti, T.-D. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0123-y · Cited by 641
Targeted Drug Delivery to Intestinal Macrophages by Bioactive Nanovesicles Released from Grapefruit
Wang, B., Zhuang, X., Deng, Z.-B., Jiang, H., Mu, J., Wang, Q., Xiang, X., Guo, H., Zhang, L., Dryden, G., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2013.190 · Cited by 634
Rathkey, J. K., Zhao, J., Liu, Z., Chen, Y., Yang, J., Kondolf, H. C., Benson, B. L., Chirieleison, S. M., Huang, A. Y., Dubyak, G. R., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aat2738 · Cited by 612
Interleukin‐18: Biological properties and role in disease pathogenesis
Kaplanski, G. (2018) · Immunological Reviews · doi:10.1111/imr.12616 · Cited by 606
Inflammasomes in carcinogenesis and anticancer immune responses
Zitvogel, L., Kepp, O., Galluzzi, L., & Kroemer, G. (2012) · Nature Immunology · doi:10.1038/ni.2224 · Cited by 593
“Two research groups have shown that a lack of Nlrp3 and Casp1 attenuates DSS-induced colitis in mic”
BackgroundThe NLRP3 inflammasome: contributions to inflammation-related diseases
Chen, Y., Ye, X., Escames, G., Lei, W., Zhang, X., Li, M., Jing, T., Yao, Y., Qiu, Z., Wang, Z., et al. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00462-9 · Cited by 492
Pattern recognition receptors and central nervous system repair
Kigerl, K. A., de Rivero Vaccari, J. P., Dietrich, W. D., Popovich, P. G., & Keane, R. W. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.01.001 · Cited by 490
Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4
Hu, B., Elinav, E., Huber, S., Booth, C. J., Strowig, T., Jin, C., Eisenbarth, S. C., & Flavell, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016814108 · Cited by 452
Emerging inflammasome effector mechanisms
Lamkanfi, M. (2011) · Nature Reviews Immunology · doi:10.1038/nri2936 · Cited by 434
Recognition of Bacteria by Inflammasomes
von Moltke, J., Ayres, J. S., Kofoed, E. M., Chavarría-Smith, J., & Vance, R. E. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095944 · Cited by 421
Role of the NLRP3 inflammasome in cancer
Moossavi, M., Parsamanesh, N., Bahrami, A., Atkin, S. L., & Sahebkar, A. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0900-3 · Cited by 417
Intestinal barrier in inflammatory bowel disease
Antoni, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i5.1165 · Cited by 413
Strategies for targeting cytokines in inflammatory bowel disease
Neurath, M. F. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-024-01008-6 · Cited by 398
Peng, Y., Yan, Y., Wan, P., Chen, D., Ding, Y., Ran, L., Mi, J., Lu, L., Zhang, Z., Li, X., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.04.005 · Cited by 389
The NLRP3 inflammasome in health and disease: the good, the bad and the ugly
Menu, P., & Vince, J. E. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04440.x · Cited by 389
Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design
Laukens, D., Brinkman, B. M., Raes, J., De Vos, M., & Vandenabeele, P. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv036 · Cited by 379
Karki, R., Man, S. M., & Kanneganti, T.-D. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0269 · Cited by 377
Normand, S., Delanoye-Crespin, A., Bressenot, A., Huot, L., Grandjean, T., Peyrin-Biroulet, L., Lemoine, Y., Hot, D., & Chamaillard, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100981108 · Cited by 355
REV-ERBα integrates colon clock with experimental colitis through regulation of NF-κB/NLRP3 axis
Wang, S., Lin, Y., Yuan, X., Li, F., Guo, L., & Wu, B. (2018) · Nature Communications · doi:10.1038/s41467-018-06568-5 · Cited by 352
The Inflammasomes in Kidney Disease
Anders, H.-J., & Muruve, D. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080798 · Cited by 351
The intestinal epithelial barrier in the control of homeostasis and immunity
Rescigno, M. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.04.003 · Cited by 345
Curcumin: an inflammasome silencer
Hasanzadeh, S., Read, M. I., Bland, A. R., Majeed, M., Jamialahmadi, T., & Sahebkar, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104921 · Cited by 327
Hu, B., Elinav, E., Huber, S., Strowig, T., Hao, L., Hafemann, A., Jin, C., Wunderlich, C., Wunderlich, T., Eisenbarth, S. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307575110 · Cited by 326
Tong, L., Hao, H., Zhang, Z., Lv, Y., Liang, X., Liu, Q., Liu, T., Gong, P., Zhang, L., Cao, F., et al. (2021) · Theranostics · doi:10.7150/thno.62046 · Cited by 325
Seo, S.-U., Kamada, N., Muñoz-Planillo, R., Kim, Y.-G., Kim, D., Koizumi, Y., Hasegawa, M., Himpsl, S. D., Browne, H. P., Lawley, T. D., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.004 · Cited by 318
“In contrast, another group found lower concentrations of several cytokines including IL-1b in colonic tissue and protection against colitis in Nlrp3 / mice (Bauer et al., 2010).”
de Rivero Vaccari, J. P., Dietrich, W. D., & Keane, R. W. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.227 · Cited by 314
Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome
Ruiz, P. A., Morón, B., Becker, H. M., Lang, S., Atrott, K., Spalinger, M. R., Scharl, M., Wojtal, K. A., Fischbeck-Terhalle, A., Frey-Wagner, I., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310297 · Cited by 314
Gut bacteria signaling to mitochondria in intestinal inflammation and cancer
Jackson, D. N., & Theiss, A. L. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1592421 · Cited by 312
Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis
Man, S. M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0054-1 · Cited by 302
Plant‐Derived Vesicle‐Like Nanoparticles as Promising Biotherapeutic Tools: Present and Future
Feng, J., Xiu, Q., Huang, Y., Troyer, Z., Li, B., & Zheng, L. (2023) · Advanced Materials · doi:10.1002/adma.202207826 · Cited by 302
Inflammatory Bowel Disease: Mechanisms, Redox Considerations, and Therapeutic Targets
Biasi, F., Leonarduzzi, G., Oteiza, P. I., & Poli, G. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4530 · Cited by 300
Guo, W., Sun, Y., Liu, W., Wu, X., Guo, L., Cai, P., Wu, X., Wu, X., Shen, Y., Shu, Y., et al. (2014) · Autophagy · doi:10.4161/auto.28374 · Cited by 297
Perera, A. P., Fernando, R., Shinde, T., Gundamaraju, R., Southam, B., Sohal, S. S., Robertson, A. A. B., Schroder, K., Kunde, D., & Eri, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-26775-w · Cited by 295
The NLRP3 inflammasome: Contributions to intestinal homeostasis
Zaki, M. H., Lamkanfi, M., & Kanneganti, T.-D. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.002 · Cited by 290
Focus on the Role of NLRP3 Inflammasome in Diseases
Fusco, R., Siracusa, R., Genovese, T., Cuzzocrea, S., & Di Paola, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124223 · Cited by 290
Inflammasomes in cancer: a double-edged sword
Kolb, R., Liu, G.-H., Janowski, A. M., Sutterwala, F. S., & Zhang, W. (2014) · Protein & Cell · doi:10.1007/s13238-013-0001-4 · Cited by 287
Interleukin-18, more than a Th1 cytokine
Novick, D., Kim, S., Kaplanski, G., & Dinarello, C. A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.014 · Cited by 280
NLR functions beyond pathogen recognition
Kufer, T. A., & Sansonetti, P. J. (2011) · Nature Immunology · doi:10.1038/ni.1985 · Cited by 279
Gao, J., Qiu, X., Xi, G., Liu, H., Zhang, F., Lv, T., & Song, Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6634 · Cited by 275
NLRP3: A promising therapeutic target for autoimmune diseases
Shen, H.-H., Yang, Y.-X., Meng, X., Luo, X.-Y., Li, X.-M., Shuai, Z.-W., Ye, D.-Q., & Pan, H.-F. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.01.020 · Cited by 271
Multiple cathepsins promote pro-IL-1β synthesis and NLRP3-mediated IL-1β activation
Orlowski, G. M., Colbert, J. D., Sharma, S., Bogyo, M., Robertson, S. A., & Rock, K. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500509 · Cited by 268
Simard, J.-C., Cesaro, A., Chapeton-Montes, J., Tardif, M., Antoine, F., Girard, D., & Tessier, P. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072138 · Cited by 262
The Many Roles of Galectin-3, a Multifaceted Molecule, in Innate Immune Responses against Pathogens
Díaz-Alvarez, L., & Ortega, E. (2017) · Mediators of Inflammation · doi:10.1155/2017/9247574 · Cited by 262
Mannose ameliorates experimental colitis by protecting intestinal barrier integrity
Dong, L., Xie, J., Wang, Y., Jiang, H., Chen, K., Li, D., Wang, J., Liu, Y., He, J., Zhou, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32505-8 · Cited by 261
Mitochondrial dysfunction in inflammatory bowel disease
Novak, E. A., & Mollen, K. P. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00062 · Cited by 259
Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome
Li, H., Guan, Y., Liang, B., Ding, P., Hou, X., Wei, W., & Ma, Y. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175091 · Cited by 258
The role of pattern recognition receptors in intestinal inflammation
Fukata, M., & Arditi, M. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.13 · Cited by 253
Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice
Bersudsky, M., Luski, L., Fishman, D., White, R. M., Ziv-Sokolovskaya, N., Dotan, S., Rider, P., Kaplanov, I., Aychek, T., Dinarello, C. A., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-303329 · Cited by 252
Toll-like receptor (TLR) and inflammasome actions in the central nervous system
Hanamsagar, R., Hanke, M. L., & Kielian, T. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.03.001 · Cited by 203
The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation
Campden, R. I., & Zhang, Y. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.02.015 · Cited by 203
Ratsimandresy, R. A., Indramohan, M., Dorfleutner, A., & Stehlik, C. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.35 · Cited by 161
Cheng, L., Jin, H., Qiang, Y., Wu, S., Yan, C., Han, M., Xiao, T., Yan, N., An, H., Zhou, X., et al. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.08.018 · Cited by 98
Oral iron exacerbates colitis and influences the intestinal microbiome
Mahalhal, A., Williams, J. M., Johnson, S., Ellaby, N., Duckworth, C. A., Burkitt, M. D., Liu, X., Hold, G. L., Campbell, B. J., Pritchard, D. M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202460 · Cited by 98
Zha, Q.-B., Wei, H.-X., Li, C.-G., Liang, Y.-D., Xu, L.-H., Bai, W.-J., Pan, H., He, X.-H., & Ouyang, D.-Y. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00597 · Cited by 95
Matsuzaki, C., Hayakawa, A., Matsumoto, K., Katoh, T., Yamamoto, K., & Hisa, K. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b01960 · Cited by 89
NOD-like receptors in intestinal homeostasis and epithelial tissue repair
Parlato, M., & Yeretssian, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069594 · Cited by 79
Mitochondrial adaptation in steatotic mice
Einer, C., Hohenester, S., Wimmer, R., Wottke, L., Artmann, R., Schulz, S., Gosmann, C., Simmons, A., Leitzinger, C., Eberhagen, C., et al. (2018) · Mitochondrion · doi:10.1016/j.mito.2017.08.015 · Cited by 72
Self-citationAchiwa, K., Ishigami, M., Ishizu, Y., Kuzuya, T., Honda, T., Hayashi, K., Hirooka, Y., Katano, Y., & Goto, H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.12.012 · Cited by 54
Wang, Y., You, K., You, Y., Li, Q., Feng, G., Ni, J., Cao, X., Zhang, X., Wang, Y., Bao, W., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106309 · Cited by 44
Zhang, L., Ye, C., Li, P., Li, C., Shu, W., Zhao, Y., & Wang, X. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03132-3 · Cited by 38
Effector functions of NLRs in the intestine: innate sensing, cell death, and disease
Yeretssian, G. (2012) · Immunologic Research · doi:10.1007/s12026-012-8317-3 · Cited by 37
Inflammasomes and the microbiota–partners in the preservation of mucosal homeostasis
Levy, M., Thaiss, C. A., Katz, M. N., Suez, J., & Elinav, E. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0451-7 · Cited by 34
NLRP3 inflammasome as therapeutic targets in inflammatory diseases
Prakash, A. V., Park, I.-H., Park, J. W., Bae, J. P., Lee, G. S., & Kang, T. J. (2023) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.099 · Cited by 31
Yao, H., Yan, J., Yin, L., & Chen, W. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2054425 · Cited by 19
Fierro-Salgado, Y. T., Reiriz, M., Beltrán-Velasco, A. I., Calleja-Conde, J., Hernández-Oñativia, X., Uceda, S., & Echeverry-Alzate, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010074 · Cited by 7
Ranjan, K. (2020) · Gastrointestinal Disorders · doi:10.3390/gidisord2030024 · Cited by 6
Metadata
- Authors
- Bauer, C., Duewell, P., Mayer, C., Lehr, H. A., Fitzgerald, K. A., Dauer, M., Tschopp, J., Endres, S., Latz, E., & Schnurr, M.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2010-05-04
- Volume
- 59
- Issue
- 9
- Pages
- 1192-1199
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2166209782
- Cited by
- 906
- References
- 37
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.